Results 111 to 120 of about 23,326 (221)

Esofagitis eosinofilíca ¿otra forma clínica de polinosis? [PDF]

open access: yes, 2017
La esofagitis eosinofílica es una enfermedad emergente en nuestro medio, en la que se produce una inflamación inmunoalérgica crónica a nivel del esófago, que ocasiona una disfunción esofágica y se caracteriza por un infiltrado de eosinófilos a nivel del ...
Calvo Gómez, David
core  

Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis

open access: yesDermatology and Therapy
Introduction Achievement of stringent outcomes (e.g., ≥ 90% improvement from baseline in Eczema Area and Severity Index [EASI 90] or minimal-to-no itch on the Worst Pruritus Numerical Rating Scale [WP-NRS 0/1]) is associated with a substantial ...
Eric L. Simpson   +14 more
doaj   +1 more source

Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study [PDF]

open access: gold
Tiago Torres   +18 more
openalex   +1 more source

Rate of dupilumab use and symptom severity of patients with chronic rhinosinusitis with nasal polyposis after Draf 3 frontal sinusotomy [PDF]

open access: bronze
Keven Seung Yong Ji   +6 more
openalex   +1 more source

Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial [PDF]

open access: green
Mario Castro   +21 more
openalex   +1 more source

Care pathways for the selection of a biologic in severe asthma [PDF]

open access: yes, 2017
Bousquet, Jean   +12 more
core   +2 more sources

Dupilumab in Elderly Patients with Atopic Dermatitis-A Systematic Review and Meta-Analysis. [PDF]

open access: yesBiomedicines
Hałubiec P   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy